A large-scale analysis has revealed independently validated gut biomarkers that can distinguish patients with inflammatory ...
A disease of unknown cause with debilitating symptoms Crohn's disease is, along with ulcerative colitis, one of the most ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...
A British study found that virtual chromoendoscopy has a higher neoplasia detection rate than other endoscopic modalities ...
By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...
For more than a decade, Michelle Hobson endured extreme fatigue, excruciating abdominal pain, and repeated hospital visits.
A ginger compound, furanodienone (FDN), has been found to reduce inflammation and repair gut damage in IBD patients by ...
The mystery of why people with IBD are also at high risk from life-threatening blood clots has been solved by scientists at ...
A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...
Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that ...
The deal with Lilly is a crucial boost for Organovo, which ended last year with just $1.2 million in cash and nearly $350 million in debt. Organovo FXR is a clinical drug program focused on farnesoid ...